Tuberculosis and Respiratory Diseases

  • 제63권4호
  • /
  • Pages.323-330
  • /
  • 2007
  • /
  • 1738-3536(pISSN)
  • /
  • 2005-6184(eISSN)
대한결핵및호흡기학회 (The Korean Academy of Tuberculosis and Respiratory Diseases)
권호 표지

흡연이 폐기능에 미치는 영향

The Effect of Smoking on Lung Function

  • 이관호 (영남대학교 의과대학 호흡기-알레르기내과)
  • Lee, Kwan Ho (Department of Internal Medicine, Yeungnam University School of Medicine)
  • 발행 : 2007.10.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Willemse BW, Postma DS, Timens W, Hacken NH. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J 2004;23:464-76 https://doi.org/10.1183/09031936.04.00012704
  2. XU X, Dokery DW, Ware JH, Speizer FE, Ferris BG Jr. Effect of cigarette smoking on rate of loss of pulmonary function in adults: a longitudinal assessment. Am Rev Respir Dis 1992;146:1345-8. https://doi.org/10.1164/ajrccm/146.5_Pt_1.1345
  3. Fletcher C, Peto R, Tink C, Speizer FE. The natural history of chronic bronchitis and emphysema. London: Oxford University Press; 1976
  4. Buist AS, Kagy JM, Sexton GJ. The effect of smoking cessation on pulmonary function: a 30-month followup of two smoking cessation clinics. Am Rev Respir Dis 1979;120:953-7
  5. Camilli AE, Burrows B, Knudson RJ, Lyle SK, Lebowitz MD. Longitudinal changes in forced expiratory volume in one second in adults: effects of smoking and smoking cessation. Am Rev Respir Dis 1987;136:794-9 https://doi.org/10.1164/ajrccm/136.3.794
  6. Lindberg A, Larsson LG, Ronmark E, Jonsson AC, Larsson K, Lundhack B. Thc1ine in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms. COPD 2007;4:5-13 https://doi.org/10.1080/15412550601168358
  7. Langhammer A, Johnsen R, Gulsvik A, Holmen TL, Bjermer L. Sex differences in lung vulnerability to tobacco smoking. Eur Respir J 2003;21:1017-23 https://doi.org/10.1183/09031936.03.00053202
  8. Paoletti P, Carrozzi L Viegi G, Modena P, Ballerin L, Di Pede F, et al. Distribution of bronchial responsiveness in a general population: effect of sex, age, smoking, and level of pulmonary function. Am J Respir Cirt Care Med 1995;151:1770-7 https://doi.org/10.1164/ajrccm.151.6.7767519
  9. Sparrow D, O'Connor GT, Rosner B, Segal MR, Weiss ST. The influence of age and level of pulmonary function on nonspecific airway responsiveness. The Nonnative Aging Study. Am Rev Respir Dis 1991;143:978-82 https://doi.org/10.1164/ajrccm/143.5_Pt_1.978
  10. Buczko GB, Day A, Vanderdoelen JL, Boucher R, Zarnel N. Effects of cigarette smoking and short-term smalling cessation on airway responsiveness to inhaled methacholine. Am Rev Respir Dis 1984;129:12-4
  11. Israel RH, Ossip-Klein DJ, Poe RH, Black P, Gerrity E, Greenblatt DW, et al. Bronchial provocation tests before and after cessation of smoking. Respiration 1988;54:247-54 https://doi.org/10.1159/000195532
  12. Lim TK, Taylor RG, Watson A, Joyce H, Pride NB. Changes in bronchial responsiveness to inhaled histamine over four years in middle aged male smokers and ex-smokers. Thorax 1988;43:509-604
  13. Wise RA, Kanner RE, Lindgren P, Connett JE, Alloee MD, Enright P4 et al. The effect of smoking Intervention and an inhaled bronchodilator on airways reactivity in COPD: the Lung Health Study. Chest 2003;124:449-58 https://doi.org/10.1378/chest.124.2.449
  14. Postma DS, de Vries K, Koeter GH, Sluiter HJ, Independent influence of reversibility of air-flow obstruction and nonspecific hyperreactivity on the long-term course of lung function in chronic air-flow obstruction. Am Rev Respir Dis 1988;134:276-80
  15. Anthonisen NR, Connett JE, Kiley JP, Allose MD, Bailey WC, Buist AS, et al. Effects of smoking intervention and the use of an inhaled anticoholinergic bronchodilator on the rate of decline of FEY1. The Lung Health Study. JAMA 1994;272:1497-605 https://doi.org/10.1001/jama.272.19.1497
  16. Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Cirt Care Med 2002; 166:675-9 https://doi.org/10.1164/rccm.2112096
  17. Scanlon PD, Connett JE, Waller LA, Altose MD, Dailey WC, Buist AS. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonaty disease. The Lung Health Study. Am J Respir Cirt Cam Med 2000;161:381-90 https://doi.org/10.1164/ajrccm.161.2.9901044
  18. Friedman CD, Siegelaub AB. Changes after quitting cigarette smoking. Circulation 1980;61:716-23 https://doi.org/10.1161/01.CIR.61.4.716
  19. Burchfiel CM, Marcus EB, Curb JD, Maclean CJ, Vollmer WM, Johnson LR, et al. Filects of smoking and smoking cessation on longitudinal decline in pulmonary function. Am J Respir Cirt Care Med 1995;151:1778-85 https://doi.org/10.1164/ajrccm.151.6.7767520
  20. Anto JM, Vermeire P, Vestbo J, Sunyer J. Epidemiology of chmnic obstructive pulmonary disease. Eur Respir J 2001;17:982-94 https://doi.org/10.1183/09031936.01.17509820
  21. Sherrill DL, Enright P, Cline M, Btmows B, Lebowitz MD, Rates of decline in lung function among subjects who restart cigarette smoking. Chest 1996;109:1001-5 https://doi.org/10.1378/chest.109.4.1001
  22. Xu X, Weiss ST, mjcken B, Schouten JP. Smoking, changes in smoking habits, and rate of decline in FEV1: new insights into gender differences. Eur Respir J 1994;7:1056-61
  23. Vestbo J, Prescott E, Lmge P. Association of chronic mucus hypersecretion sith FEV1 decline and chronic obstructive pulmonary disease. Copenhagen City Heart Study. Am J Respir Cirt Care Med 1996;153:1630-5
  24. Prescott E, Bjerg AM, Andersen PK, Lange P, Vestbo J. Gender difference in smoking effects on hmg function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J 1997;10:822-7
  25. Lange VJ. Can GOLD stage 0 provide information of prognostic value in Chronic Obstructive Pulmonary Disease? Am Rev Respir Grit Cam Med 2002;166: 329-32